Healthcare resource utilization with adjunctive cariprazine and other atypical antipsychotics in patients with major depressive disorder
Although causality cannot be determined from these real-world findings, results suggest that in patients with MDD, initiating adjunctive cariprazine is associated with significantly lower HRU for certain outcomes relative to other AAs.
Authors
- Anita H. Clayton (ORCID: https://orcid.org/0000-0003-4372-0879)
- Nicholas A. Cummings
- Daniel Mercer
- Nadia Nabulsi (ORCID: https://orcid.org/0000-0003-0632-6311)
- Andrew Rava
- Sun Haiyan
- Mousam Parikh
- Oscar Hayes
- Tracy Yee
Institutions
- AbbVie (United States) (US)
- Genesis Research Institute (JP)
- AbbVie (Japan)
- University of Virginia (US)
Publication Details
- Journal
- Current Medical Research and Opinion
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1080/03007995.2025.2465617
- Citations
- 2
- Primary Topic
- Treatment of Major Depression
- Type
- article
- Field-Weighted Citation Impact
- 2.79